NM_001252024.2:c.3549G>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001252024.2(TRPM1):​c.3549G>C​(p.Gln1183His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.005 in 1,612,564 control chromosomes in the GnomAD database, including 28 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. Q1183Q) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0035 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0052 ( 26 hom. )

Consequence

TRPM1
NM_001252024.2 missense

Scores

1
6
11

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.725

Publications

13 publications found
Variant links:
Genes affected
TRPM1 (HGNC:7146): (transient receptor potential cation channel subfamily M member 1) This gene encodes a member of the transient receptor potential melastatin subfamily of transient receptor potential ion channels. The encoded protein is a calcium permeable cation channel that is expressed in melanocytes and may play a role in melanin synthesis. Specific mutations in this gene are the cause autosomal recessive complete congenital stationary night blindness-1C. The expression of this protein is inversely correlated with melanoma aggressiveness and as such it is used as a prognostic marker for melanoma metastasis. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Oct 2011]
TRPM1 Gene-Disease associations (from GenCC):
  • congenital stationary night blindness 1C
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • TRPM1-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • congenital stationary night blindness
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0092971325).
BP6
Variant 15-31026219-C-G is Benign according to our data. Variant chr15-31026219-C-G is described in ClinVar as Likely_benign. ClinVar VariationId is 167747.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00347 (529/152380) while in subpopulation NFE AF = 0.0055 (374/68044). AF 95% confidence interval is 0.00504. There are 2 homozygotes in GnomAd4. There are 245 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001252024.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TRPM1
NM_001252024.2
MANE Select
c.3549G>Cp.Gln1183His
missense
Exon 27 of 28NP_001238953.1
TRPM1
NM_001252020.2
c.3600G>Cp.Gln1200His
missense
Exon 26 of 27NP_001238949.1
TRPM1
NM_002420.6
c.3483G>Cp.Gln1161His
missense
Exon 26 of 27NP_002411.3

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TRPM1
ENST00000256552.11
TSL:1 MANE Select
c.3549G>Cp.Gln1183His
missense
Exon 27 of 28ENSP00000256552.7
TRPM1
ENST00000558445.6
TSL:1
c.3600G>Cp.Gln1200His
missense
Exon 26 of 27ENSP00000452946.2
TRPM1
ENST00000397795.7
TSL:1
c.3483G>Cp.Gln1161His
missense
Exon 26 of 27ENSP00000380897.2

Frequencies

GnomAD3 genomes
AF:
0.00347
AC:
529
AN:
152262
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000844
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00419
Gnomad ASJ
AF:
0.00779
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00165
Gnomad FIN
AF:
0.00141
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00550
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00364
AC:
902
AN:
248122
AF XY:
0.00379
show subpopulations
Gnomad AFR exome
AF:
0.000710
Gnomad AMR exome
AF:
0.00191
Gnomad ASJ exome
AF:
0.00636
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00123
Gnomad NFE exome
AF:
0.00542
Gnomad OTH exome
AF:
0.00364
GnomAD4 exome
AF:
0.00516
AC:
7540
AN:
1460184
Hom.:
26
Cov.:
32
AF XY:
0.00503
AC XY:
3655
AN XY:
726504
show subpopulations
African (AFR)
AF:
0.000747
AC:
25
AN:
33478
American (AMR)
AF:
0.00221
AC:
99
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00627
AC:
164
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00337
AC:
291
AN:
86252
European-Finnish (FIN)
AF:
0.00143
AC:
74
AN:
51758
Middle Eastern (MID)
AF:
0.00243
AC:
14
AN:
5768
European-Non Finnish (NFE)
AF:
0.00591
AC:
6567
AN:
1111990
Other (OTH)
AF:
0.00505
AC:
305
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
452
904
1357
1809
2261
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
256
512
768
1024
1280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00347
AC:
529
AN:
152380
Hom.:
2
Cov.:
33
AF XY:
0.00329
AC XY:
245
AN XY:
74520
show subpopulations
African (AFR)
AF:
0.000841
AC:
35
AN:
41600
American (AMR)
AF:
0.00418
AC:
64
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00779
AC:
27
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00165
AC:
8
AN:
4834
European-Finnish (FIN)
AF:
0.00141
AC:
15
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00550
AC:
374
AN:
68044
Other (OTH)
AF:
0.00284
AC:
6
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
30
60
89
119
149
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00487
Hom.:
1
Bravo
AF:
0.00318
TwinsUK
AF:
0.00701
AC:
26
ALSPAC
AF:
0.00649
AC:
25
ESP6500AA
AF:
0.00118
AC:
5
ESP6500EA
AF:
0.00424
AC:
36
ExAC
AF:
0.00368
AC:
446
Asia WGS
AF:
0.00173
AC:
6
AN:
3478
EpiCase
AF:
0.00518
EpiControl
AF:
0.00539

ClinVar

Significance: Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Jan 15, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Sep 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TRPM1: BP4, BS2

Clinical Genetics, Academic Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not specified Benign:1
Apr 28, 2015
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Congenital stationary night blindness 1C Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.27
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.43
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Benign
0.32
T
Eigen
Benign
0.14
Eigen_PC
Benign
0.084
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Pathogenic
0.98
D
M_CAP
Benign
0.019
T
MetaRNN
Benign
0.0093
T
MetaSVM
Benign
-0.96
T
MutationAssessor
Uncertain
2.7
M
PhyloP100
0.72
PrimateAI
Uncertain
0.49
T
PROVEAN
Uncertain
-3.1
D
REVEL
Benign
0.17
Sift
Benign
0.037
D
Sift4G
Uncertain
0.0040
D
Polyphen
0.79
P
Vest4
0.44
MutPred
0.32
Loss of helix (P = 0.0558)
MVP
0.39
MPC
0.24
ClinPred
0.048
T
GERP RS
-0.35
Varity_R
0.33
gMVP
0.56
Mutation Taster
=42/58
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs182549235; hg19: chr15-31318422; API